Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Teva

    Tag: teva

    You Searched For "Teva"
    Oklahoma judge approves Teva Pharma USD 85 million opioid settlement

    Oklahoma judge approves Teva Pharma USD 85 million opioid settlement

    Medical Dialogues Bureau25 Jun 2019 9:00 AM IST
    U.S: An Oklahoma judge on Monday approved a revised $85 million settlement with Teva Pharmaceutical Industries Ltd (Teva Pharma) resolving claims by...
    Sun pharma, Dr Reddys, others deny allegations of price fixing in US

    Sun pharma, Dr Reddys, others deny allegations of price fixing in US

    Garima16 May 2019 9:35 AM IST
    In separate clarifications to stock exchanges, the companies including Glenmark, Sun Pharma, Dr Reddy's, Aurobindo Pharma denied the accusations and...
    Inflated prices to 1000 per cent; Lupin, Sun Pharma, Dr Reddys, others face lawsuit

    Inflated prices to 1000 per cent; Lupin, Sun Pharma, Dr Reddys, others face lawsuit

    Farhat Nasim14 May 2019 4:57 PM IST
    Mumbai: In a major setback, a group of domestic pharmaceutical companies including Zydus Cadila, Lupin, Aurobindo Pharma, Dr Reddy's Labs, Wockhardt,...
    Eli Lilly new migraine drug Emgality pulls ahead of Amgen in battle for prescriptions

    Eli Lilly new migraine drug Emgality pulls ahead of Amgen in battle for prescriptions

    Farhat Nasim12 May 2019 9:30 AM IST
    Weekly U.S. prescription data from IQVIA, an analytics provider to the life sciences industry, showed that Lilly's therapy Emgality claimed the...
    Pharma giant Teva resists Israel PM on closure plan

    Pharma giant Teva resists Israel PM on closure plan

    Ruby Khatun Khatun21 Dec 2017 9:30 AM IST
    Jerusalem: Teva, the world's largest generic drug company, refused Tuesday to reconsider a decision to close its Jerusalem plant despite pressure from...
    Roche lymphoma drug drives high remission rate, longer survival: study

    Roche lymphoma drug drives high remission rate, longer survival: study

    Ruby Khatun Khatun12 Dec 2017 10:00 AM IST
    An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced,...
    Teva

    Teva's new CEO shakes up management, to combine divisions

    Ruby Khatun Khatun30 Nov 2017 9:15 AM IST
    TEL AVIV: Teva Pharmaceutical Industries Ltd's new chief executive officer ousted the company's three top division heads on Monday as he works to turn...
    Natco pharma partner Mylan gets USFDA nod for multiple sclerosis injection

    Natco pharma partner Mylan gets USFDA nod for multiple sclerosis injection

    Ruby Khatun Khatun4 Oct 2017 10:55 AM IST
    New Delhi: The US Food and Drug Administration has granted approval to drug major Natco Pharma's marketing partner Mylan's Glatiramer Acetate...
    Teva to sell contraceptive brand Paragard in 1.1 billion dollar deal

    Teva to sell contraceptive brand Paragard in 1.1 billion dollar deal

    Ruby Khatun Khatun13 Sept 2017 1:43 PM IST
    Teva Pharmaceutical Industries, on Monday, agreed to sell its contraceptive brand Paragard to a unit of Cooper Cos for $1.1 billion, on a day the...
    Drugmaker Teva hires Lundbeck CEO Schultz to restore its health

    Drugmaker Teva hires Lundbeck CEO Schultz to restore its health

    Ruby Khatun Khatun12 Sept 2017 9:47 AM IST
    JERUSALEM/COPENHAGEN: Teva poached Lundbeck's Kare Schultz as its new chief executive on Monday, handing the drugs industry veteran the urgent task of...
    New AstraZeneca, Amgen drug looks strong rival in severe asthma

    New AstraZeneca, Amgen drug looks strong rival in severe asthma

    Ruby Khatun Khatun11 Sept 2017 10:27 AM IST
    LONDON: A new kind of injectable biotech treatment for severe asthma from AstraZeneca and Amgen promises to help a much broader range of patients than...
    Next

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok